Erez Vigodman
2016
In 2016, Erez Vigodman earned a total compensation of $6.5M as Former President and CEO at Teva Pharmaceutical Industries, a 12% decrease compared to previous year.
Compensation breakdown
| Option Awards | $2,250,061 |
|---|---|
| Salary | $1,528,437 |
| Stock Awards | $2,249,948 |
| Other | $478,671 |
| Total | $6,507,117 |
Vigodman received $2.3M in option awards, accounting for 35% of the total pay in 2016.
Vigodman also received $1.5M in salary, $2.2M in stock awards and $478.7K in other compensation.
Rankings
In 2016, Erez Vigodman's compensation ranked 1,067th out of 14,075 executives tracked by ExecPay. In other words, Vigodman earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,067 out of 14,075 | 92nd |
Division Manufacturing | 356 out of 5,489 | 94th |
Major group Chemicals And Allied Products | 92 out of 1,895 | 95th |
Industry group Drugs | 60 out of 1,538 | 96th |
Industry Pharmaceutical Preparations | 51 out of 1,176 | 96th |
Source: SEC filing on April 25, 2018.
Vigodman's colleagues
We found three more compensation records of executives who worked with Erez Vigodman at Teva Pharmaceutical Industries in 2016.